Assessing Outcomes in Patients With Multiple Myeloma Postautologous Stem Cell Transplantation: Contrasting the Effects of Melphalan Dosages at 200 mg/m2 versus 140 mg/m2

Authors: Brown, Zachary, Scott, Campbell, Zhang, Li Fang, Sadek, Ramses, Clarke, Andrea, Jillella, Anand, Keruakous, Amany R., Clemmons, Amber B.

Source: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24(9):642-647

Light Chain–Predominant Multiple Myeloma Subgroup: Impaired Renal Function Correlates with Decreased Survival

Authors: Singh, Gurmukh, Savage, Natasha M, Jillella, Anand P, Bollag, Roni J

Source: Laboratory medicine. 53(2):145-148

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100144120224.0x000001&indx=1&recIds=ETOCvdc_100144120224.0x000001

Role of indoleamine 2, 3-dioxygenase in acute myeloid leukemia

Authors: Sobash, Philip T, Kolhe, Ravindra, Karim, Nagla Abdel, Guddati, Achuta K, Jillella, Anand, Kota, Vamsi

Source: Future oncology. 16(36):3085-3094

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187796217.0x000001&indx=1&recIds=ETOCvdc_100187796217.0x000001

Identifying Candidates for Effective Utilization of Stored Autologous PBSCs in Salvage Transplantation for Multiple Myeloma: Who Benefits Most?

Authors: Keruakous, Amany R., Walker, Laura, Denlinger, Molly, Mian, Mohammad A. H., Bradshaw, Danielle, Kota, Vamsi K., Jillella, Anand P.

Source: Hematology Reports; Sep2024, Vol. 16 Issue 3, p479-486, 8p

Subject Terms: BISPECIFIC antibodies, STEM cell transplantation, HEMATOPOIETIC stem cells, OLDER patients, MULTIPLE myeloma

CT-448 Academic Center Outreach to Community Practices Increases Transplant Referrals and Possibly Reduces Racial Disparities

Authors: Kota, Vamsi, Bryan, Locke, Chauhan, Ayushi, Mian, Mohammed, Keruakous, Amany, Cortes, Jorge, Jillella, Anand

Source: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S445-S445

A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML

Authors: Fathi, Amir T., Erba, Harry P., Lancet, Jeffrey E., Stein, Eytan M., Ravandi, Farhad, Faderl, Stefan, Walter, Roland B., Advani, Anjali S., DeAngelo, Daniel J., Kovacsovics, Tibor J., Jillella, Anand, Bixby, Dale, Levy, Moshe Y., O'Meara, Megan M., Ho, Phoenix A., Voellinger, Jenna, Stein, Anthony S.

Source: In Blood 13 September 2018 132(11):1125-1133

A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

Authors: Stein, Eytan M., Walter, Roland B., Erba, Harry P., Fathi, Amir T., Advani, Anjali S., Lancet, Jeffrey E., Ravandi, Farhad, Kovacsovics, Tibor, DeAngelo, Daniel J., Bixby, Dale, Faderl, Stefan, Jillella, Anand P., Ho, Phoenix A., O'Meara, Megan M., Zhao, Baiteng, Biddle-Snead, Charles, Stein, Anthony S.

Source: In Blood 25 January 2018 131(4):387-396

Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease

Authors: Khoury, Hanna, Langston, Amelia, Kota, Vamsi, Wilkinson, Jennifer, Pusic, Iskra, Jillella, Anand, Bauer, Stephanie, Kim, Audrey, Roberts, Danielle, Al-Kadhimi, Zaid, Bodo, Imre, Winton, Elliott, Arellano, Martha, DiPersio, John

Source: Bone marrow transplantation. 53(7):826-831

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111630993.0x000001&indx=1&recIds=ETOCvdc_100111630993.0x000001

Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?

Authors: DeFilipp, Zachariah, Langston, Amelia A., Chen, Zhengjia, Zhang, Chao, Arellano, Martha L., El Rassi, Fuad, Flowers, Christopher R., Kota, Vamsi K., Al-Kadhimi, Zaid, Veldman, Rachel, Jillella, Anand P., Lonial, Sagar, Waller, Edmund K., Khoury, Hanna J.

Source: In Clinical Lymphoma Myeloma and Leukemia August 2016 16(8):466-471

Comparative Incidence of Relapse and Progression Free Survival in Morbidly Obese Vs. Non-Morbidly Obese Multiple Myeloma Patients Who Have Undergone Autologous Stem Cell Transplantations

Authors: Le, Thuy Kim, Sircar, Daniel, Mian, Mohammad A H, Jillella, Anand P, Fox, Ashley, Bryan, Locke J, Anwar, Tahsin, Bradshaw, Danielle, Kolhe, Ravindra, Savage, Natasha, Kota, Vamsi

Source: Transplantation and Cellular Therapy. 28(S):S425-S426

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100159730169.0x000001&indx=1&recIds=ETOCvdc_100159730169.0x000001

Academic Center Outreach to Community Practices Increases Transplant Referrals and Possibly Reduce Racial Disparities

Authors: Kota, Vamsi, Anwar, Tahiya, Malhotra, Sean, Anwar, Tahsin, Anwar, Mohammad, Jimenez, Sarah, Corley, Courtney, Green, Kimberly, Giddens, Gita, Worthington, Courtney, Harmon, Kerrie, Ashley, Rachel, Shishkina, Irina, Chauhan, Ayushi, Keruakous, Amany, Kolhe, Ravindra, Savage, Natasha, Clarke, Andrea, Clemmons, Amber B., Cortes, Jorge E., Bryan, Locke J, Jillella, Anand P

Source: Transplantation and Cellular Therapy. 28(S):S482-S483

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157888359.0x000001&indx=1&recIds=ETOCvdc_100157888359.0x000001

A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL): Results of the ECOG-ACRIN EA9131 Trial

Authors: Jillella, Anand P., Lee, Sandra J. ^*, Altman, Jessica K., Luger, Selina M., Tallman, Martin S., Foran, James M., Law, Lisa Y., Bryan, Locke J., Abou Zahr, Abdallah ^*, Begna, Kebede, Perl, Alexander, Vadakara, Joseph, Sanchez, Federico ^*, Bergan, Raymond C. ^*, Fisch, Michael J. ^*, Carlos, Ruth C. ^*, Wagner, Lynne I. ^*, Litzow, Mark R., Kota, Vamsi K.

Source: In Blood 15 November 2022 140 Supplement 1:1011-1013

Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies

Authors: Hamadani, Mehdi, Kochuparambil, S. Thomas, Osman, Salman, Cumpston, Aaron, Leadmon, Sonia, Bunner, Pamela, Watkins, Kathy, Morrison, Devi, Speir, Ethan, DeRemer, David, Kota, Vamsi, Jillella, Anand, Craig, Michael, Awan, Farrukh

Source: In Biology of Blood and Marrow Transplantation July 2012 18(7):1128-1135

Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib

Authors: Kota, Vamsi K., Kong, Jee Hyun, Arellano, Martha, El Rassi, Fuad, Gaddh, Manila, Heffner, Leonard T., Winton, Elliott F., Jillella, Anand P., McLemore, Morgan L., Khoury, H. Jean

Source: Clinical lymphoma, myeloma & leukemia. 17(12):e71-e73

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100060903860.0x000001&indx=1&recIds=ETOCvdc_100060903860.0x000001

Poster: CT-448 Academic Center Outreach to Community Practices Increases Transplant Referrals and Possibly Reduces Racial Disparities

Authors: Kota, Vamsi, Bryan, Locke, Chauhan, Ayushi, Mian, Mohammed, Keruakous, Amany, Cortes, Jorge, Jillella, Anand

Source: Clinical lymphoma, myeloma & leukemia. 22(S2):S188-S188

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172882732.0x000001&indx=1&recIds=ETOCvdc_100172882732.0x000001

P-140: Outreach and satellite transplant clinics increase multiple myeloma (MM) transplant referrals and specifically transplant referrals of African American patients

Authors: Jillella, Anand, Mian, Mohammad A.H., Keruakous, Amany, Cortes, Jorge, Chauhan, Ayushi, Bryan, Locke, Walker, Laura, James, Molly, Kota, Vamsi

Source: Clinical lymphoma, myeloma & leukemia. 22(S):S112-S112

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100169001300.0x000001&indx=1&recIds=ETOCvdc_100169001300.0x000001

Recurrent Adult Choroid Plexus Carcinoma Treated with High-Dose Chemotherapy and Syngeneic Stem Cell (Bone Marrow) Transplant

Authors: Samuel, Thomas, Parikh, Jigarkumar, Sharma, Suash, Giller, Cole, Sterling, Kristen, Kapoor, Suraj, Pirkle, Christen, Jillella, Anand

Source: Journal of neurological surgery.Part A.Central European neurosurgery. 74(1):e149-e154

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100154151845.0x000001&indx=1&recIds=ETOCvdc_100154151845.0x000001

Outcomes for Patients with Multiple Myeloma after Receipt of Melphalan 200mg/m2 Versus 140 Mg/m2 for Autologous Stem Cell Transplantation

Authors: Scott, Campbell, Brown, Zachary, Fang Zhang, Li, Sadek, Ramses, Keruakous, Amany, Jillella, Anand, Clemmons, Amber B

Source: In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S452-S452

Blood Product Support in Multiple Myeloma Patients Undergoing Autologous Bone Marrow Transplantation May Predict Improved Outcome.

Authors: Pavkov, Isabela L, Shoukier, Mahran, Mian, Mohammad AH, Stokes, Michael, Reategui, Yazmin, Nain, Priyanshu, Bradshaw, Danielle, Jillella, Anand, Kota, Vamsi

Source: In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S393-S393

Elevated Ferritin Prior to Collection and Mobilization May Predict Low Stem Cell Yield

Authors: Weeks, Charles Joseph, Bradshaw, Danielle, Mian, Mohammad A H, Shah, Anvay, Kim, Katherine J, Abbagoni, Sujith, Jillella, Anand P, Kota, Vamsi

Source: In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S155-S156